Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126123871 | 12612387 | 1 | I | 20160720 | 20160801 | 20160801 | PER | US-TEVA-679302USA | TEVA | 0.00 | F | Y | 56.75000 | KG | 20160802 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126123871 | 12612387 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Intramuscular | 20 MILLIGRAM DAILY; | N | 20622 | 20 | MG | INJECTION | QD | |||||
| 126123871 | 12612387 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | U | 0 | TABLET | TID | ||||||||
| 126123871 | 12612387 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MILLIGRAM DAILY; | N | M81422 | 0 | 75 | MG | CAPSULE | BID | ||||
| 126123871 | 12612387 | 4 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 4 MILLIGRAM DAILY; | 0 | 2 | MG | TABLET | BID | ||||||
| 126123871 | 12612387 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MILLIGRAM DAILY; | 0 | 25 | MG | TABLET | QD | ||||||
| 126123871 | 12612387 | 6 | C | TIZANIDINE. | TIZANIDINE | 1 | Oral | AS NEEDED | 0 | 4 | MG | TABLET | |||||||
| 126123871 | 12612387 | 7 | C | MYRBETRIQ | MIRABEGRON | 1 | Oral | 75 MILLIGRAM DAILY; | 0 | 75 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126123871 | 12612387 | 1 | Multiple sclerosis |
| 126123871 | 12612387 | 2 | Major depression |
| 126123871 | 12612387 | 3 | Neuralgia |
| 126123871 | 12612387 | 4 | Anxiety |
| 126123871 | 12612387 | 5 | Anxiety |
| 126123871 | 12612387 | 7 | Urinary incontinence |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126123871 | 12612387 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126123871 | 12612387 | Anxiety | |
| 126123871 | 12612387 | Depression | |
| 126123871 | 12612387 | Incorrect route of drug administration | |
| 126123871 | 12612387 | Multiple sclerosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126123871 | 12612387 | 1 | 2008 | 0 | ||
| 126123871 | 12612387 | 2 | 2015 | 0 | ||
| 126123871 | 12612387 | 3 | 201606 | 0 | ||
| 126123871 | 12612387 | 4 | 2008 | 0 | ||
| 126123871 | 12612387 | 5 | 201504 | 0 | ||
| 126123871 | 12612387 | 6 | 201502 | 0 | ||
| 126123871 | 12612387 | 7 | 201502 | 0 |